CDAK
COM:CODIAKBIO
VentureRadar
- Stock
market
STOCKSindustry
Technologywebsite
codiakbio.comcrunchbase
codiak-biosciencesipo date
Oct 14, 2020
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The compan...Show More